Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS

被引:36
|
作者
Caglar, Gamze Sinem [1 ]
Kahyaoglu, Inci [1 ]
Pabuccu, Recai [1 ]
Demirtas, Selda [2 ]
Seker, Rabia [2 ]
机构
[1] Univ Ufuk, Fac Med, Dept Obstet & Gynecol Mevlana Bulvari Balgat, TR-06520 Ankara, Turkey
[2] Univ Ufuk, Fac Med, Dept Biochem, Ankara, Turkey
关键词
Anti-Mullerian hormone; Polycystic ovary; Insulin resistance; POLYCYSTIC-OVARY-SYNDROME; ANTRAL FOLLICLE COUNT; INHIBITING SUBSTANCE; METFORMIN THERAPY; ANOVULATORY WOMEN; REPRODUCTIVE AGE; SERUM; CELLS; AMH; SENSITIVITY;
D O I
10.1007/s00404-013-2833-9
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
This study is designed to explore the correlation between AMH levels and IR in normal weight PCOS women. This prospective study was conducted on 55 patients, who were admitted to obstetrics and gynecology department of a university clinic. Study group was consisted of 34 patients diagnosed as polycystic ovary syndrome (PCOS) according to the Rotterdam Criteria, whereas control group was consisted of 21 healthy volunteers without any features of clinical or biochemical hyperandrogenism, who had regular menstrual cycles. BMI a parts per thousand yen 25 kg/m(2) were considered overweight and obese and excluded. Blood samples were obtained during days 2-3 after spontaneous menses or progesterone-induced withdrawal bleeding after overnight fasting for at least 12 h. The weight, height, hip and waist circumferences of the patients were measured. Fasting insulin and glucose (FPG) levels were used for calculating different insulin resistance indexes (Homeostatic Model Assessment (HOMA-IR), Quantitative Insulin Sensitivity Check Index (QUICKI)). No significant difference was found between PCOS and control groups regarding the mean age, BMI, waist to hip ratio (WHR), mean values of FPG, FPG/insulin ratio and HOMA B (p > 0.05). AMH values were significantly higher in PCOS cases when compared with controls (4.7 vs. 3.4 ng/mL) (p < 0.05).The mean values of HOMA-IR and QUICKI indexes were significantly higher among PCOS cases when compared with controls. E2 levels were significantly lower and Total-T were significantly higher in PCOS patients. When PCOS cases are categorized according to the existence of IR, no difference in Total-T and AMH levels between both groups. Although not statistically significant, a negative correlation of AMH with HOMA-IR and a positive correlation with QUICKI index were found. Among the hormone parameters, AMH was found to be positively correlated with Total-T (r = 0.332, p = 0.013). Although the relation between AMH and androgen production is supported by current evidence, the mechanism underlying the relation between AMH and insulin resistance is not clear yet.
引用
收藏
页码:905 / 910
页数:6
相关论文
共 50 条
  • [1] Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS
    Gamze Sinem Caglar
    Inci Kahyaoglu
    Recai Pabuccu
    Selda Demirtas
    Rabia Seker
    Archives of Gynecology and Obstetrics, 2013, 288 : 905 - 910
  • [2] Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome
    Fonseca, Helena Proni
    Brondi, Renata Suzuki
    Piovesan, Fernanda Xavier
    Miklos, Thomas Gabriel
    Aldrighi, Jose Mendes
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (09) : 667 - 670
  • [3] Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients
    Wiweko, Budi
    Maidarti, Mila
    Priangga, M. Dwi
    Shafira, Nadia
    Fernando, Darrell
    Sumapraja, Kanadi
    Natadisastra, Muharam
    Hestiantoro, Andon
    JOURNAL OF ASSISTED REPRODUCTION AND GENETICS, 2014, 31 (10) : 1311 - 1316
  • [4] Anti-Mullerian Hormone in Pathogenesis, Diagnostic and Treatment of PCOS
    Rudnicka, Ewa
    Kunicki, Michal
    Calik-Ksepka, Anna
    Suchta, Katarzyna
    Duszewska, Anna
    Smolarczyk, Katarzyna
    Smolarczyk, Roman
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (22)
  • [5] Anti-Mullerian Hormone in PCOS: A Review Informing International Guidelines
    Teede, Helena
    Misso, Marie
    Tassone, Eliza C.
    Dewailly, Didier
    Ng, Ernest Hy
    Azziz, Ricardo
    Norman, Robert J.
    Andersen, Marianne
    Franks, Stephen
    Hoeger, Kathleen
    Hutchison, Samantha
    Oberfield, Sharon
    Shah, Duru
    Hohmann, Femke
    Ottey, Sasha
    Dabadghao, Preeti
    Laven, Joop S. E.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2019, 30 (07) : 467 - 478
  • [6] Anti-Mullerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population
    Bozdag, Gurkan
    Mumusoglu, Sezcan
    Coskun, Zuhal Yapici
    Yarali, Hakan
    Yildiz, Bulent Okan
    REPRODUCTIVE BIOMEDICINE ONLINE, 2019, 39 (03) : 522 - 529
  • [7] Anti-Mullerian hormone - a predictor of ovarian reserve
    Meden-Vrtovec, Helena
    Osredkar, Josko
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2010, 79 (06): : 507 - 511
  • [8] Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women
    Stracquadanio, M.
    Ciotta, L.
    Palumbo, M. A.
    GYNECOLOGICAL ENDOCRINOLOGY, 2018, 34 (03) : 223 - 228
  • [9] Functional analysis of rare anti-Mullerian hormone protein-altering variants identified in women with PCOS
    Meng, L.
    McLuskey, A.
    Dunaif, A.
    Visser, J. A.
    MOLECULAR HUMAN REPRODUCTION, 2023, 29 (05)
  • [10] Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS)
    Park, Hyun T.
    Cho, Geum J.
    Ahn, Ki H.
    Shin, Jung H.
    Kim, Young T.
    Hur, Jun Y.
    Kim, Sun H.
    Lee, Kyu W.
    Kim, Tak
    CLINICAL ENDOCRINOLOGY, 2010, 72 (01) : 26 - 31